Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 970 - WOMEN'S HEALTH CODE › Subpart A - GENERAL PROVISIONS › Section 970.10 - Definitions

Current through Register Vol. 48, No. 28, July 12, 2024
"Act" means Sections 2310-347 and 2310-350 of the Department
				  of Public Health Powers and Duties Law of the Civil Administrative Code of
				  Illinois [20 ILCS 2310/2310-347 and 2310 -350].
"Applicant" means any eligible physician, hospital,
				  laboratory, education institution, other organization or person in Illinois
				  whose intent is to conduct breast, cervical, and ovarian cancer research;public
				  or private entities in Illinois whose intent is to conduct research concerning
				  breast cancer or to fund services for breast cancer victims; or any of the
				  above whose intent is to support a fellowship in the area of breast, cervical,
				  and ovarian cancer. (Section 21.5 of the Illinois Lottery Law)
"Breast, Cervical, and Ovarian Cancer Advisory Committee"
				  means a committee chaired by the Director or his/her designee and composed of
				  at least six additional members appointed by the Director, of which four must
				  be representatives of the State Board of Health, Y-Me, Susan G. Komen
				  Foundation, and American Cancer Society-Illinois Chapter and the remaining
				  individuals must be knowledgeable of either breast, cervical, or ovarian cancer
				  or representative of an at-risk population. With the exception of the Chair, no
				  appointee shall be an employee of the Department.
"Breast Cancer" means malignant tumor of the breast
				  characterized by uncontrolled, abnormally rapid division of cells that
				  originate in the breast and surrounding tissue and may spread to other
				  organs.
"Cervical Cancer" means malignant tumor of the narrow lower
				  end or neck of the uterus (cervix) characterized by uncontrolled, abnormally
				  rapid division of cells that originate in the cervix and surrounding tissue and
				  may spread to other organs.
"Clinical Diagnosis" means the process of identifying a
				  disease by its characteristic signs, symptoms and laboratory findings.
"Clinical Trial" means the testing of diagnostic, treatment,
				  and prevention techniques by comparing results in patients randomly assigned to
				  receive one of two or more techniques being tested.
"Cure" means the eradication of disease through removal of
				  the risk of death invoked by the disease that was treated.
"Department" means the Illinois Department of Public
				  Health.
"Detection" means the discovery of breast, cervical, or
				  ovarian cancer in a woman previously thought to be free of such cancer.
"Diagnostic Evaluation" means use of various techniques
				  including physical exams, mammography, and evaluation by a pathologist of
				  breast, cervical, or ovarian cells removed from the body to determine the
				  presence and type of cancer.
"Director" means the Director of the Illinois Department of
				  Public Health.
"Early Detection" means discovery of breast, cervical, or
				  ovarian cancer at the first possible time when spread to other organs is least
				  likely to occur.
"Fellowship" means supervised practical experience for an
				  individual in a health care or scientific specialty beyond that required to
				  earn a doctorate or, in the case of medicine, beyond that provided to hospital
				  resident physicians to broaden expertise in breast, cervical, and ovarian
				  cancer.
"Funding Period" means the time (usually twelve months
				  coinciding with the Department's Fiscal Year) during which money is to be spent
				  in support of a particular research project or training course.
"General Award" means presentation of funds by the Department
				  to an applicant to conduct research on breast, cervical, and/or ovarian cancer
				  and for funding services to breast cancer victims.
"Governmental Unit Code" means the Illinois Comptroller's
				  preassigned vendor identification number for governmental agencies and
				  municipalities.
"Grant Agreement Period" (see Funding Period).
"Not-for-Profit" means a corporation as described in the
				  General Not-for-Profit Corporation Act of 1986 [805 ILCS 105 ].
"Ovarian Cancer" means malignant tumor of the ovaries
				  characterized by uncontrolled, abnormally rapid division of cells, which
				  originates in the ovaries and may spread to other organs.
"Peer Review Panel" means a group appointed by the Director,
				  whose members demonstrate and are acknowledged to have expertise in areas
				  dealing with breast, cervical, and ovarian cancer research.
"Prevention" means using various techniques including drugs,
				  diet, and/or lifestyle changes to stop cancer from developing in healthy
				  women.
"Principal Investigator" means the person with prime
				  responsibility for conducting a research project.
"Project Period" means a minimum of one year and a maximum of
				  three years (possibility of two continuation grants).
"Referral" means the process of linking persons who may be or
				  who have been diagnosed with breast, cervical, and ovarian cancer with services
				  in response to those needs.
"Research" means a scientific investigation into possible
				  causes, location, progression, treatment, care and cure for breast, cervical,
				  and ovarian cancer. Research includes, but is not limited to, expenditures to
				  develop and advance the understanding, techniques, and modalities effective in
				  early detection, prevention, cure, screening, and treatment of breast,
				  cervical, and ovarian cancer and may include clinical trials. (Section 2310-350
				  of the Act)
"Research Fund" means the Penny Severns Breast, Cervical, and
				  Ovarian Cancer Research Fund, which is a special fund in the State Treasury as
				  described in Section 2310-350 of the Civil Administrative Code of
				  Illinois.
"Research Fund Checkoff" means a voluntary process by which
				  an Illinois taxpayer may use a provision on the standard individual income tax
				  form to contribute to the Penny Severns Breast, Cervical, and Ovarian Cancer
				  Research Fund.
"Research Grant" means funding provided to qualified
				  principal investigators to investigate specific questions related to breast,
				  cervical, and ovarian cancer research.
"Services for Breast Cancer Victims" means any type of
				  assistance to aid in the lives of victims of breast cancer.
"Services for Breast Cancer Victims Grants" means funding to
				  non-research grantees that provide services to breast cancer victims.
"Screening" means examining and testing for cancer in women
				  who have no overt symptoms of cancer.
"Ticket for the Cure Board" means an advisory board within
				  the Department created by Section 2310-347 of the Act.
"Ticket for the Cure Fund" means a special fund created by
				  Section 21.5 of the Illinois Lottery Law [20 ILCS 1605 ].
"TIN" means the nine digit federal Taxpayer Identification
				  Number that includes the Federal Employer Identification Number (FEIN), Social
				  Security Number, or Governmental Unit Code.
"Training and Continuing Education" means extending or
				  updating the knowledge of research scientists, health care professionals and
				  other allied persons.
"Treatment" means the management and care of a woman for the
				  purpose of combating breast, cervical, or ovarian cancer.